Knowledge Center
Patent / Jan 24, 2019
Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease
Source:
WO 2019016512 20190124
The present invention relates to an amorphous form of vilanterol trifenatate, processes for its prepn. and its use in pharmaceutical formulations for the treatment of respiratory diseases, particularly for the treatment of asthma and chronic obstructive pulmonary disease.Ìý In particular, the invention relates to an amorphous form of vilanterol trifenatate, characterized by the x-ray powder diffraction (XRPD) pattern, obtained using copper K-α1 radiation.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Aug 06, 2015
A process for control of particle size distribution of active pharmaceutical ingredients
Read more
Scientific Article
/ Apr 01, 2015
Microparticles, preparation and purification methods, molecularly imprinted polymer layer, pharmaceuticals
Read more
Scientific Article